FluidForm Bio
Michael Graffeo is the CEO and co-founder of FluidForm, a company focused on 3D bioprinting technology for building human tissue. Prior to this, Michael worked as the VP of Business Development at Insulet Corporation, VP of Global Sales and Marketing at OvaScience, and VP of Marketing & Sales at Dune Medical Devices. Michael has also held positions at Hologic, Cytyc Corporation, DePuy Mitek, Cordis, and Abiomed. Michael holds an MBA from Harvard Business School and degrees in Mechanical Engineering and Engineering Physics from Cornell University.
This person is not in any teams
FluidForm Bio
FluidForm Bio™ is creating living human tissue for better treatment of disease. Our patented FRESH™ technology is a revolutionary platform designed to build tissue using cells, proteins, and nothing else. Through partnerships with top life science companies, our technology has been validated to produce the highest quality tissue in a variety of applications. We deliver human tissue that is indistinguishable from the real thing by integrating breakthrough innovations in 3D printing, computational and synthetic biology, AI, and advanced materials science. Our living tissue will offer therapies to countless patients who deserve better treatment options.